Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anvesh Rathore

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|February 4, 2026
Primary ovarian diffuse large B-cell lymphomaParvinder Singh, V S Prakash, Anvesh Rathore, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern IndiaH S Darling, Sundaram Viswanath, Rajeshwar Singh, et al.
Medical Journal, Armed Forces India|March 27, 2023
Cancer trends and burden among Armed Forces personnel, veterans and their families: Cancer registry data analysis from tertiary care hospitalAmol Patel, R Shankaran, H P Singh, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
A clinicoepidemiological and management profile of metastatic carcinoma gallbladder in the northeast part of Indian patients in a tertiary care centerAnvesh Rathore, Abhishek Pathak, Subhash Ranjan, et al.
BMC Cancer|August 18, 2025
A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohortNihanthy D Sreenath, Suresh Pandalanghat, Amul Kapoor, et al.
Medical Journal, Armed Forces India|January 28, 2025
Real world experience on patterns of usage and toxicity profile of immunotherapy drugs in Indian patients: A prospective observational studyM R Kaushik, Amul Kapoor, H P Singh, et al.
Ecancermedicalscience|March 5, 2024
Real world study of safety and efficacy of lorlatinib as second line and beyond in <i>ALK</i>-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND)Bivas Biswas, Nikhil S Ghadyalpatil, Shekar Patil, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|February 4, 2026
Primary ovarian diffuse large B-cell lymphomaParvinder Singh, V S Prakash, Anvesh Rathore, et al.
Journal of Cancer Research and Therapeutics|September 15, 2020
A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern IndiaH S Darling, Sundaram Viswanath, Rajeshwar Singh, et al.
Medical Journal, Armed Forces India|March 27, 2023
Cancer trends and burden among Armed Forces personnel, veterans and their families: Cancer registry data analysis from tertiary care hospitalAmol Patel, R Shankaran, H P Singh, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
A clinicoepidemiological and management profile of metastatic carcinoma gallbladder in the northeast part of Indian patients in a tertiary care centerAnvesh Rathore, Abhishek Pathak, Subhash Ranjan, et al.
BMC Cancer|August 18, 2025
A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohortNihanthy D Sreenath, Suresh Pandalanghat, Amul Kapoor, et al.
Medical Journal, Armed Forces India|January 28, 2025
Real world experience on patterns of usage and toxicity profile of immunotherapy drugs in Indian patients: A prospective observational studyM R Kaushik, Amul Kapoor, H P Singh, et al.
Ecancermedicalscience|March 5, 2024
Real world study of safety and efficacy of lorlatinib as second line and beyond in <i>ALK</i>-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND)Bivas Biswas, Nikhil S Ghadyalpatil, Shekar Patil, et al.
Pageof 1